Wanfu Biotech announced that Wang Jihua, the controlling shareholder, actual controller and chairman, increased his shareholding in the company from August 4 to 8 to 6, 2026. Prior to the increase in holdings, Wang Jihua held 495.47 million shares, accounting for 10.59% of the total share capital; Wang Jihua and his co-actors held a total of 147 million shares, accounting for 31.5% of the total share capital. This time, the holdings were increased by 1.156 million shares, accounting for 0.2470% of the total share capital, and a cumulative increase of 2.0441 million yuan. After the increase in holdings, Wang Jihua's shareholding ratio rose to 10.84%, and his total shareholding ratio with those acting in concert rose to 31.74%. This increase in holdings is exempt from issuing an offer, and the company has fulfilled its information disclosure obligations at this stage.

Wanfu Biotech announced that Wang Jihua, the controlling shareholder, actual controller and chairman, increased his shareholding in the company from August 4 to 8 to 6, 2026. Prior to the increase in holdings, Wang Jihua held 495.47 million shares, accounting for 10.59% of the total share capital; Wang Jihua and his co-actors held a total of 147 million shares, accounting for 31.5% of the total share capital. This time, the holdings were increased by 1.156 million shares, accounting for 0.2470% of the total share capital, and a cumulative increase of 2.0441 million yuan. After the increase in holdings, Wang Jihua's shareholding ratio rose to 10.84%, and his total shareholding ratio with those acting in concert rose to 31.74%. This increase in holdings is exempt from issuing an offer, and the company has fulfilled its information disclosure obligations at this stage.